Costs Spike for 2nd- and 3rd-Line ARVs and Late Treatment

The cost to treat HIV-positive people with second- and third-line antiretrovirals jumps by a respective 24 and 41 percent compared with first-line therapies, reports the National AIDS Treatment Advocacy Project .

http://www.poz.com/rssredir/articles/therapy_cost_761_24530.shtml